论文部分内容阅读
目的观察奥扎格雷联合丁苯肽注射液治疗急性脑梗死的临床疗效。方法选取2011年2月-2012年2月医院收治的急性脑梗死患者120例,随机分为观察组和对照组各60例。对照组给予常规基础治疗。观察组在上述基础治疗之上给予奥扎格雷治疗。比较2组临床效果。结果观察组总有效率为96.7%明显高于对照组的86.7%,差异有统计学意义(P<0.05)。结论结果表明奥扎格雷联合丁苯肽注射液治疗急性脑梗死的疗效显著,不良反应少。值得临床推广应用。
Objective To observe the clinical efficacy of ozagrel combined with dipyridamole injection in the treatment of acute cerebral infarction. Methods A total of 120 acute cerebral infarction patients admitted from February 2011 to February 2012 in our hospital were randomly divided into observation group (60 cases) and control group (60 cases). The control group was given routine basic treatment. The observation group was given ozagrel therapy above the above basic treatment. The clinical effects of two groups were compared. Results The total effective rate in observation group was 96.7%, which was significantly higher than that in control group (86.7%, P <0.05). Conclusion The results show that the combination of ozagrel and DBP in the treatment of acute cerebral infarction has significant curative effect and few adverse reactions. Worthy of clinical application.